Apogee Therapeutics (APGE) Retained Earnings (2022 - 2026)
Apogee Therapeutics (APGE) posted quarterly Retained Earnings of -$749000.0 for Q1 2026, up 99.79% year-over-year from -$374888.6 in Q1 2025, and down 169.35% quarter-over-quarter from $1.1 million in Q4 2025.
Apogee Therapeutics (APGE) Retained Earnings (2022 - 2026) Analysis & Trends
Apogee Therapeutics (APGE) has reported Retained Earnings for 5 consecutive years, with -$749000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Retained Earnings rose 99.79% year-over-year to -$749000.0; the TTM figure through Mar 2026 stood at -$749000.0 (up 99.79% YoY), while the FY2025 annual figure was $1.1 million, down 99.89% from the prior year.
- Retained Earnings eased to -$749000.0 in Q1 2026 per APGE's latest filing, from $1.1 million in the prior quarter.
- Across five years, Retained Earnings topped out at $1.1 billion in Q3 2025 and bottomed at -$427.4 million in Q2 2025.
- Historically, Retained Earnings has averaged $66.9 million across 5 years, with a median of -$749000.0 in 2026.
- Annual changes were most pronounced in 2024 — Retained Earnings surged 310475.68% — and 2025, when it plunged 203998.87%.
- Apogee Therapeutics' Retained Earnings stood at -$39.8 million in 2022, then soared by 100.83% to $329000.0 in 2023, then soared by 310475.68% to $1.0 billion in 2024, then sank by 99.89% to $1.1 million in 2025, then plunged by 169.35% to -$749000.0 in 2026.
- Business Quant data shows APGE's Retained Earnings at -$749000.0 in Q1 2026, $1.1 million in Q4 2025, and $1.1 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Apogee Therapeutics | 10.14 Bn | 9.16 Bn | - | 1.92 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.92 Bn |
| Mar 31, 2026 | -749,000.00 |
| Dec 31, 2025 | 1.08 Mn |
| Sep 30, 2025 | 1.08 Bn |
| Jun 30, 2025 | -427.35 Mn |
| Mar 31, 2025 | -361.26 Mn |
| Dec 31, 2024 | 1.02 Bn |
| Sep 30, 2024 | -238.70 Mn |
| Jun 30, 2024 | -289,000.00 |
| Mar 31, 2024 | -177,000.00 |
| Dec 31, 2023 | 329,000.00 |
| Sep 30, 2023 | -92.04 Mn |
| Jun 30, 2023 | -71.20 Mn |
| Dec 31, 2022 | -39.79 Mn |